Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

about

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

Item

http://www.wikidata.org/entity/Q43865605

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@en

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@nl

type

Item

label

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@en

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@nl

prefLabel

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@en

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@nl

P1476

Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.

@en

P2093

Peter M O Owira

http://www.w3.org/2001/XMLSchema#string

Sanelisiwe Nzuza

http://www.w3.org/2001/XMLSchema#string

Sindiswa Zondi

http://www.w3.org/2001/XMLSchema#string

P2860

The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Antidiabetic properties of dietary flavonoids: a cellular mechanism review

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.

HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.

Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice.

Understanding diabetes in patients with HIV/AIDS

Protease Inhibitors for Patients With HIV-1 Infection: A Comparative Overview.

Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?

Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults.

P304

e0183355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183355

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29121676

http://www.w3.org/2001/XMLSchema#string

P932

5679664

http://www.w3.org/2001/XMLSchema#string